The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Dillaha Larry since year 2005.
The trader's CIK number is 1360463.
At the time of this reporting, Dillaha Larry is the EVP & Chief Medical of Insys Therapeutics, Inc. .
(stock ticker symbol INSY).
See this page for all insider trading activities at Insys Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2014-03-05||INSY||Insys Therapeutics, Inc.||Sale||149,932||79.79||11,962,924|
|2014-03-05||INSY||Insys Therapeutics, Inc.||Option Ex||149,932||5.42||812,631|
|2008-08-11||SCRX||First Horizon Pharmaceutical Corp||Sale||875||20.34||17,794|
|2008-04-25||SCRX||First Horizon Pharmaceutical Corp||Sale||350||19.35||6,772|
|2008-02-20||SCRX||First Horizon Pharmaceutical Corp||Sale||875||22.54||19,722|
|2008-01-23||SCRX||First Horizon Pharmaceutical Corp||Sale||438||22.44||9,826|
|2007-12-07||SCRX||First Horizon Pharmaceutical Corp||Sale||2,563||22.75||58,308|
|2007-10-10||SCRX||First Horizon Pharmaceutical Corp||Sale||3,500||28.00||98,000|
|2007-02-21||SCRX||First Horizon Pharmaceutical Corp||Sale||1,688||23.89||40,326|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dillaha Larry (EVP & Chief Medical of Insys Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.